Crexavibart
Modify Date: 2024-01-21 19:15:23
Crexavibart structure
|
Common Name | Crexavibart | ||
|---|---|---|---|---|
| CAS Number | 2599039-61-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CrexavibartCrexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain[1]. |
| Name | Crexavibart |
|---|
| Description | Crexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain[1]. |
|---|---|
| Related Catalog | |
| Target |
SARS-CoV2[1] |
| No Any Chemical & Physical Properties |